Healthy Adult Males
Conditions
Interventions
Intake of standardized meals
Sponsors
Otsuka Pharmaceutical Co., Ltd.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Individuals who provided written informed consent to participate in this trial. 2) Healthy adult males aged 20 to 65 years. 3) Individuals who are able to follow the investigator's instructions and adhere to the scheduled intake of the 15N-Glycine and the standardized meals, blood sampling, urine collection, and maintenance of rest.
Exclusion criteria
Exclusion criteria: 1) Individuals judged by the principal investigator to be ineligible for this trial based on the results of the preliminary medical examination. 2) Individuals who showed a high-sensitivity CRP level of >= 0.2 mg/dL or an albumin level of < 3.8 g/dL at the time of the preliminary medical examination. 3) Individuals with diseases of the gastrointestinal, cardiovascular, or endocrine systems, or with a history of such conditions, as well as those who regularly take medications for the treatment of these diseases, who are judged by the principal investigator to be ineligible for this trial. 4) Individuals with food allergies. 5) Individuals who have had 200 mL or more of whole blood collected within the past 4 weeks, or 400 mL or more within the past 12 weeks prior to the first blood sampling. 6) Individuals who are currently participating in another trial or are scheduled to participate in another trial. 7) Individuals who are judged to be ineligible for this trial for other reasons by the principal investigator or the study director.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relationship between protein metabolism indicators and blood component concentrations. | — |
Countries
Japan
Contacts
Public ContactShoichiro Inoue
Otsuka Pharmaceutical Co., Ltd. Advanced Research Institute for Core Science
Outcome results
None listed